Related Experiment Video

Updated: Jul 7, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Atypical protein kinase C dysfunction and the metabolic syndrome

Francesco Beguinot1, Pietro Formisano

  • 1Dipartimento di Biologia e Patologia Cellulare e Molecolare, Federico II University of Naples Medical School, Via Sergio Pansini 5, Naples, Italy. beguino@unina.it

Trends in Endocrinology and Metabolism: TEM
|February 26, 2008
PubMed

Insights

Selective ablation of protein kinase C-lambda in muscle induces metabolic syndrome in mice. This deficiency impairs glucose uptake, leading to insulin resistance, obesity, and dyslipidemia, mimicking human metabolic syndrome.

Area of Science:

  • Biochemistry
  • Metabolic research
  • Molecular biology

Background:

  • Atypical protein kinase C (aPKC) isoforms regulate glucose uptake in insulin-sensitive tissues.
  • Reduced aPKC activity in muscle is linked to human insulin resistance.
  • Protein kinase C-lambda (PKC-λ) is a key aPKC isoform.

Purpose of the Study:

  • To investigate the role of PKC-λ in muscle by creating a mouse model with selective PKC-λ ablation in muscle tissue.
  • To determine if PKC-λ deficiency in muscle is sufficient to cause metabolic syndrome.

Main Methods:

  • Generation of a novel mouse model with muscle-specific PKC-λ knockout.
  • Comprehensive phenotyping of the knockout mice to assess metabolic parameters.

Main Results:

  • Mice with muscle-specific PKC-λ ablation exhibited systemic insulin resistance.
  • These mice showed reduced glucose tolerance, a hallmark of diabetes.
  • Abdominal obesity and dyslipidemia were observed, mirroring human metabolic syndrome.

Conclusions:

  • Muscle-specific deficiency of atypical protein kinase C-lambda is sufficient to induce a metabolic syndrome phenotype in mice.
  • PKC-λ plays a critical role in maintaining metabolic homeostasis.
  • Targeting PKC-λ in muscle may offer a therapeutic strategy for metabolic disorders.

Related Concept Videos

Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...